DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Panacos Attracts $18.3M Round To Fund HIV Drug Development (BioWorld Today)
News | 04. 16. 2008
Panacos Pharmaceuticals
Panacos Pharmaceuticals Inc. raised $18.3 million in its Series C round of financing.
